Page last updated: 2024-09-03

3-(2,4-dimethoxybenzylidene)anabaseine and tubocurarine

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with tubocurarine in 1 studies

Compound Research Comparison

Studies
(3-(2,4-dimethoxybenzylidene)anabaseine)
Trials
(3-(2,4-dimethoxybenzylidene)anabaseine)
Recent Studies (post-2010)
(3-(2,4-dimethoxybenzylidene)anabaseine)
Studies
(tubocurarine)
Trials
(tubocurarine)
Recent Studies (post-2010) (tubocurarine)
1668814,66114952

Protein Interaction Comparison

ProteinTaxonomy3-(2,4-dimethoxybenzylidene)anabaseine (IC50)tubocurarine (IC50)
Multidrug resistance-associated protein 4Homo sapiens (human)9.6
Multidrug and toxin extrusion protein 1Homo sapiens (human)9.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, T; Ma, Q; Tabassum, N; Wu, G; Yu, R1

Other Studies

1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and tubocurarine

ArticleYear
Exploring the binding energy profiles of full agonists, partial agonists, and antagonists of the α7 nicotinic acetylcholine receptor.
    Journal of molecular modeling, 2017, Volume: 23, Issue:9

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Anabasine; Benzylidene Compounds; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Humans; Indoles; Ligands; Lobeline; Molecular Docking Simulation; Nicotinic Agonists; Nicotinic Antagonists; Protein Binding; Pyridines; Strychnine; Tropisetron; Tubocurarine

2017